ur mission is to improve the quality of human life by enabling people to do more, feel better and live longer. We are a research based pharmaceutical company. We are committed to tackling the three "priority" diseases identified by the World Health Organisation: HIV/AIDS, tuberculosis and malaria. Our business employs around 99,000 people in over 100 countries. Around 12,800 people work in our research teams to discover new medicines. We screen about 65 million compounds every year in our search for new medicines. Our vaccines are included in immunisation campaigns in 182 countries worldwide. We delivered 1.4 billion vaccine doses in 2009, of which nearly 1 billion were shipped for use in developing countries. In November 2009, we launched ViiV Healthcare, a global specialist HIV company established by GlaxoSmithKline and Pfizer to deliver advances in treatment and care for people living with HIV. In July 2009 we acquired Stiefel Lab.